Quantcast
Last updated on April 17, 2014 at 13:45 EDT

Latest Aripiprazole Stories

2014-03-28 12:26:07

DUBLIN, March 28, 2014 /PRNewswire/ -- Dublin - Research and Markets ( http://www.researchandmarkets.com/research/cw7xqm/investigation) has announced the addition of the "Investigation Report on China's Aripiprazole Market, 2009-2018" [http://www.researchandmarkets.com/research/cw7xqm/investigation ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Schizophrenia is a common mental disorder. Data shows that mental illness has...

2014-03-17 12:27:36

Ameritox offers medical and behavioral health professionals additional information in helping to assess medication non-adherence by those diagnosed with serious mental health issues BALTIMORE, March 17, 2014 /PRNewswire/ -- Ameritox(SM), the nation's leader in medication monitoring solutions, introduced a new method to assist physicians in assessing medication non-adherence for patients with serious mental illness prescribed the antipsychotic drug Abilify, the top-selling medication...

2013-11-13 04:23:04

LONDON, November 13, 2013 /PRNewswire/ -- First-in-class antipsychotic therapy for Schizophrenia and Bipolar Disorders Zysis, a private pharmaceutical company optimising therapies for disorders of the Central Nervous System, today announced that the United States Patent and Trademark Office has granted U.S. patent 8,575,172 covering its Phase II ready Long Acting Oral Aripiprazole Once Weekly (LAO Aripiprazole OW) product, a first-in-class antipsychotic therapy for...

2013-10-14 08:25:33

Drug Launches Will Not Offset a Decline in Major-Market Sales Caused By Increasing Generic Competition For Atypical Antipsychotics, According to a New Report from Decision Resources BURLINGTON, Mass., Oct. 14, 2013 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that Dainippon Sumitomo Pharma/Sunovion/Takeda Pharmaceutical's atypical antipsychotic Latuda will experience significant uptake in the...

2013-08-01 08:35:52

A Brand New English Site for Viewers Worldwide: http://www.otsuka.co.jp/en TOKYO, Aug. 1, 2013 /PRNewswire/ -- Otsuka Pharmaceutical Co., Ltd. launched a newly designed English corporate website that was collaborated with an Amsterdam-based creative agency to reflect our philosophy: "Otsuka-people creating new products for better health worldwide." With additional new content designed creatively, the new website adopts an innovative, personal design to attract people from around the...

2013-06-06 12:28:39

MONTREAL, June 6, 2013 /CNW/ - Abilify® (aripiprazole) has received an additional approval from Health Canada as an adjunct, or add-on, treatment to antidepressants for the treatment of major depressive disorder (MDD) in adults who had an inadequate response to prior antidepressant treatments during the current episode. When used with an antidepressant, Abilify has been shown to improve the symptoms of adults living with MDD who had an inadequate response to at least two trials...

2013-05-01 08:32:04

Surveyed U.S. Psychiatrists Expect to Prescribe Edivoxetine to 25 Percent of Their Patients with Treatment-Resistant Depression, According to a New Report from Decision Resources BURLINGTON, Mass., May 1, 2013 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that a greater effect on depressive symptoms than current treatments is one of the greatest unmet needs in patients with...

2012-03-02 05:53:58

(Ivanhoe Newswire)-- Elderly folks ages 65 and up who are living in a nursing home and taking certain antipsychotic medications for dementia could be hastening their death. The Harvard Medical School undertook the largest study ever among US nursing home residents, researchers looked at 75,445 older nursing home residents from 45 US states between 2001 and 2005. All nursing home residents studied were at least 65 years of age. Risks of mortality were examined over a 6 months period. The...

Antipsychotic Medication Death Rate Among Dementia Patients Analyzed
2012-02-27 06:21:22

A new Harvard Medical School (HMS) and Brigham and Women's Hospital study has discovered that some types of antipsychotic medication present more of a risk of death in older dementia patients than others. According to MedPage Today North American Correspondent Michael Smith, Dr. Krista Huybrechts of the Boston hospital and colleagues looked at six medications used to treat dementia in more than 75,000 nursing home residents over the age of 65 who had started using the drugs between 2001...

2012-02-23 18:00:25

Research: Differential risk of death in older nursing home residents prescribed specific antipsychotic medications: Population-based cohort study Nursing home residents over the age of 65 who take certain antipsychotic medication for dementia are at an increased risk of death, suggests a research paper published today on bmj.com. The Harvard Medical School study, the largest ever undertaken among US nursing home residents, looked at 75,445 older nursing home residents from 45 US states...